Since its creation in 2001, the Life sciences team at Seventure Partners has always been visionary in its investment policy – looking for innovative products that are one step ahead of market expectations.
We have pioneered industrial biotechnology investment since our inception (starting with our investment into Metabolic Explorer). Since 2005, we have supported converging health and nutrition sectors by investing in agro-food companies bringing health benefits to people. In 2008 we identified the microbiome as key area for future development and we have provided significant staffing and financial resources to this field.
Today, Seventure Partners and Health for Life CapitalTM are known worldwide for their leadership in this area. Since we have worked in this field, we were involved in establishing and funding Enterome in 2011, as well as Maat Pharma and Targedys and invested in many others such as LNC, Eligo, Vedanta, Daytwo, Biomx, etc….